Aspire Biopharma Files Amended 2025 Annual Report
Ticker: ASBP · Form: 10-K/A · Filed: Apr 8, 2026 · CIK: 0001847345
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Aspire Biopharma amended its 2025 10-K. Check financials.
AI Summary
Aspire Biopharma Holdings, Inc. filed an amended 10-K report on April 8, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as financial statements and certifications. The company's principal business is in Pharmaceutical Preparations.
Why It Matters
This amended filing provides updated financial and operational details for Aspire Biopharma Holdings, Inc., crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This is a routine amended filing of an annual report, not indicating new or elevated risks.
Key Numbers
- 2265424 — iXBRL 10-K/A Size (Size of the main 10-K/A filing document in bytes.)
- 8568196 — Complete submission text file Size (Size of the complete submission text file in bytes.)
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Filer of the 10-K/A
- 0001847345 (company) — CIK number for Aspire Biopharma Holdings, Inc.
- 2026-04-08 (date) — Filing date of the 10-K/A
- 2025-12-31 (date) — Period of report for the 10-K/A
- 2834 (company) — SIC code for Pharmaceutical Preparations
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for Aspire Biopharma Holdings, Inc. for the period ending December 31, 2025.
When was this amended filing accepted by the SEC?
The amended 10-K/A filing was accepted by the SEC on April 8, 2026.
What is Aspire Biopharma Holdings, Inc.'s SIC code?
Aspire Biopharma Holdings, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the CIK number for Aspire Biopharma Holdings, Inc.?
The CIK number for Aspire Biopharma Holdings, Inc. is 0001847345.
Where is Aspire Biopharma Holdings, Inc. located?
Aspire Biopharma Holdings, Inc. has its mailing and business address at 23150 FASHION DRIVE, SUITE 232, ESTERO FL 33928.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 8, 2026 regarding Aspire Biopharma Holdings, Inc. (ASBP).